Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
Rev Med Suisse ; 1(26): 1750-4, 2005 Jun 29.
Article in French | MEDLINE | ID: mdl-16117050

ABSTRACT

Substance abuse touches around a quarter of psychiatric patients, which brings up various therapeutic problems. Literature shows us that between the "parallel", "series" and "integrated" approaches, it is the integrated approach which proves to be the most effective in terms of reducing symptoms, hospitalisations and criminality. An improvement in the patients' quality of life can also be observed. The integrated approach is developed by a team of in-patient and out-patient workers, whose job is to identify and evaluate clinically the motivation and the psychological and social functioning of the patients, and to propose suitable treatments according to the pathology and context of each case. A designated "case manager" guarantees the long term therapeutic project for each patient.


Subject(s)
Mental Disorders/diagnosis , Mental Disorders/rehabilitation , Substance-Related Disorders/diagnosis , Substance-Related Disorders/rehabilitation , Diagnosis, Dual (Psychiatry) , Humans , Patient Care Team
2.
Am J Pathol ; 159(1): 273-83, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11438474

ABSTRACT

Viral infection is one environmental factor that has been implicated as a precipitating event that may initiate beta-cell damage during the development of diabetes. This study examines the mechanisms by which the viral replicative intermediate, double-stranded (ds) RNA impairs beta-cell function and induces beta-cell death. The synthetic dsRNA molecule polyinosinic-polycytidylic acid (poly IC) stimulates beta-cell DNA damage and apoptosis without impairing islet secretory function. In contrast, the combination of poly IC and interferon (IFN)-gamma stimulates DNA damage, apoptosis, and necrosis of islet cells, and this damage is associated with the inhibition of glucose-stimulated insulin secretion. Nitric oxide mediates the inhibitory and destructive actions of poly IC + IFN-gamma on insulin secretion and islet cell necrosis. Inhibitors of nitric oxide synthase, aminoguanidine, and N(G)-monomethyl-L-arginine, attenuate poly IC + IFN-gamma-induced DNA damage to levels observed in response to poly IC alone, prevent islet cell necrosis, and prevent the inhibitory actions on glucose-stimulated insulin secretion. N(G)-monomethyl-L-arginine fails to prevent poly IC- and poly IC + IFN-gamma-induced islet cell apoptosis. PKR, the dsRNA-dependent protein kinase that mediates the antiviral response in infected cells, is required for poly IC- and poly IC + IFN-gamma-induced islet cell apoptosis, but not nitric oxide-mediated islet cell necrosis. Alone, poly IC fails to stimulate DNA damage in islets isolated from PKR-deficient mice; however, nitric oxide-dependent DNA damage induced by the combination of poly IC + IFN-gamma is not attenuated by the genetic absence of PKR. These findings indicate that dsRNA stimulates PKR-dependent islet cell apoptosis, an event that is associated with normal islet secretory function. In contrast, poly IC + IFN-gamma-induced inhibition of glucose-stimulated insulin secretion and islet cell necrosis are events that are mediated by islet production of nitric oxide. These findings suggest that at least one IFN-gamma-induced antiviral response (islet cell necrosis) is mediated through a PKR-independent pathway.


Subject(s)
Interferon-gamma/pharmacology , Islets of Langerhans/physiology , Poly I-C/pharmacology , RNA, Double-Stranded/pharmacology , Animals , Apoptosis/physiology , Cell Death/physiology , Cells, Cultured , DNA Damage/physiology , Drug Synergism , Glucose/pharmacology , Insulin/metabolism , Insulin Secretion , Islets of Langerhans/metabolism , Islets of Langerhans/ultrastructure , Male , Mice , Mice, Inbred C57BL , Mice, Knockout/genetics , Microscopy, Electron , Necrosis , Nitric Oxide/physiology , Protein Kinases/physiology , Rats , Rats, Sprague-Dawley , eIF-2 Kinase/physiology
3.
Mol Cell ; 7(6): 1165-76, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11430820

ABSTRACT

The accumulation of unfolded protein in the endoplasmic reticulum (ER) attenuates protein synthesis initiation through phosphorylation of the alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha) at Ser51. Subsequently, transcription of genes encoding adaptive functions including the glucose-regulated proteins is induced. We show that eIF2alpha phosphorylation is required for translation attenuation, transcriptional induction, and survival in response to ER stress. Mice with a homozygous mutation at the eIF2alpha phosphorylation site (Ser51Ala) died within 18 hr after birth due to hypoglycemia associated with defective gluconeogenesis. In addition, homozygous mutant embryos and neonates displayed a deficiency in pancreatic beta cells. The results demonstrate that regulation of translation through eIF2alpha phosphorylation is essential for the ER stress response and in vivo glucose homeostasis.


Subject(s)
DNA-Binding Proteins/genetics , Glucose/metabolism , Heat-Shock Proteins , Homeostasis/physiology , Hypoglycemia/metabolism , Protein Biosynthesis/physiology , Transcription Factors/genetics , Activating Transcription Factors , Animals , Animals, Newborn , Blood Proteins/genetics , Blood Proteins/metabolism , CCAAT-Enhancer-Binding Proteins/genetics , CCAAT-Enhancer-Binding Proteins/metabolism , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Survival/physiology , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/metabolism , Endoplasmic Reticulum/metabolism , Endoplasmic Reticulum Chaperone BiP , Gene Expression/physiology , Germ-Line Mutation , Gluconeogenesis/physiology , Homozygote , Hypoglycemia/genetics , Islets of Langerhans/cytology , Islets of Langerhans/metabolism , Mice , Mice, Mutant Strains , Molecular Chaperones/genetics , Molecular Chaperones/metabolism , Mutagenesis/physiology , Phosphorylation , Protein Folding , RNA, Messenger/analysis , Transcription Factor CHOP , Transcription Factors/chemistry , Transcription Factors/metabolism , Transcriptional Activation/physiology
4.
EMBO J ; 19(14): 3630-8, 2000 Jul 17.
Article in English | MEDLINE | ID: mdl-10899117

ABSTRACT

In this study, the role of the double-stranded (ds) RNA-dependent protein kinase (PKR) in macrophage activation was examined. dsRNA [polyinosinic:polycytidylic acid (poly IC)]-stimulated inducible nitric oxide synthase, interleukin (IL)-1alpha and IL-1beta mRNA expression, nitrite formation and IL-1 release are attenuated in RAW264.7 cells stably expressing dominant negative (dn) mutants of PKR. The transcriptional regulator nuclear factor (NF)-kappaB is activated by dsRNA, and appears to be required for dsRNA-induced macrophage activation. While dnPKR mutants prevent macrophage activation, they fail to attenuate dsRNA-induced IkappaB degradation or NF-kappaB nuclear localization. The inhibitory actions of dnPKR on dsRNA-induced macrophage activation can be overcome by treatment with interferon (IFN)-gamma, an event associated with PKR degradation. Furthermore, dsRNA + IFN-gamma stimulate inducible nitric oxide synthase expression, IkappaB degradation and NF-kappaB nuclear localization to similar levels in macrophages isolated from PKR(-/-) and PKR(+/+) mice. These findings indicate that both NF-kappaB and PKR are required for dsRNA-induced macrophage activation; however, dsRNA-induced NF-kappaB activation occurs by PKR-independent mechanisms in macrophages. In addition, the PKR dependence of dsRNA-induced macrophage activation can be overcome by IFN-gamma.


Subject(s)
Macrophage Activation/drug effects , Macrophages, Peritoneal/enzymology , RNA, Double-Stranded/pharmacology , eIF-2 Kinase/metabolism , Animals , Cell Line , Cells, Cultured , Enzyme Induction/drug effects , I-kappa B Proteins/metabolism , Interferon-gamma/pharmacology , Interleukin-1/genetics , Interleukin-1/metabolism , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/metabolism , Mice , Mice, Knockout , Mutation , NF-kappa B/metabolism , Nitric Oxide/metabolism , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Poly I-C/pharmacology , RNA, Double-Stranded/antagonists & inhibitors , RNA, Messenger/metabolism , Signal Transduction/drug effects , eIF-2 Kinase/antagonists & inhibitors , eIF-2 Kinase/deficiency , eIF-2 Kinase/genetics
5.
Exp Neurol ; 155(2): 221-7, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10072297

ABSTRACT

When ischemic brain is reperfused, there is in vulnerable neurons immediate inhibition of protein synthesis associated with a large increase in phosphorylation of the alpha-subunit of eukaryotic initiation factor 2 [eIF2alpha, phosphorylated form eIF2alpha(P)]. We examined eIF2alpha kinase and eIF2alpha(P) phosphatase activity in brain homogenate postmitochondrial supernatants obtained from rats after 3 to 30 min of global brain ischemia (cardiac arrest), after 5 min of ischemia and 5 min of reperfusion (5R), and after 10 min of ischemia and 90 min reperfusion (90R). Because it has been suggested that PKR might be specifically responsible for producing eIF2alpha(P) during reperfusion, we also examined in brain homogenates from wild-type and PKR0/0 C57BL/6J x 129/SV mice the effect of 5 min of ischemia and 5 min of reperfusion on eIF2alpha(P). Cytosolic brain eIF2alpha(P) in the 5R and 90R rats was 18- and 23-fold that of nonischemic controls without any change in the rate of eIF2alpha(P) dephosphorylation. There was no change in eIF2alpha kinase activity between 3 and 30 min of ischemia but an 85% decrease in the 5R group; the 90R group was similar to controls. In wild-type and PKR0/0 mice total eIF2alpha was identical, and there was an identical 16-fold increase in eIF2alpha(P) at 5 min of reperfusion. Our observations contradict hypotheses that PKR activation, loss of eIF2alpha(P) phosphatase activity, or any general increase in eIF2alpha kinase activity are responsible for reperfusion-induced phosphorylation of eIF2alpha, and we suggest that the mechanism may involve regulation of the availability of eIF2alpha to a kinase.


Subject(s)
Ischemic Attack, Transient/enzymology , Phosphoprotein Phosphatases/metabolism , Reperfusion Injury/enzymology , eIF-2 Kinase/metabolism , Animals , Autoradiography , Blotting, Western , Brain/enzymology , Mice , Mice, Inbred C57BL , Phosphoprotein Phosphatases/biosynthesis , Phosphorylation , Rats , Rats, Long-Evans , eIF-2 Kinase/biosynthesis
6.
Nat Med ; 2(8): 864-70, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8705854

ABSTRACT

To determine whether the presenilin 1 (PS1), presenilin 2 (PS2) and amyloid beta-protein precursor (APP) mutations linked to familial Alzheimer's disease (FAD) increase the extracellular concentration of amyloid beta-protein (A beta) ending at A beta 42(43) in vivo, we performed a blinded comparison of plasma A beta levels in carriers of these mutations and controls. A beta 1-42(43) was elevated in plasma from subjects with FAD-linked PS1 (P < 0.0001), PS2N1411 (P = 0.009), APPK670N,M671L (P < 0.0001), and APPV7171 (one subject) mutations. A beta ending at A beta 42(43) was also significantly elevated in fibroblast media from subjects with PS1 (P < 0.0001) or PS2 (P = 0.03) mutations. These findings indicate that the FAD-linked mutations may all cause Alzhelmer's disease by increasing the extracellular concentration of A beta 42(43), thereby fostering cerebral deposition of this highly amyloidogenic peptide.


Subject(s)
Alzheimer Disease/genetics , Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/genetics , Membrane Proteins/genetics , Mutation , Alzheimer Disease/blood , Amyloid beta-Peptides/blood , Cells, Cultured , Culture Media, Conditioned , Female , Fibroblasts , Humans , Male , Peptide Fragments/blood , Presenilin-1 , Presenilin-2
7.
Cell Mol Neurobiol ; 14(3): 245-57, 1994 Jun.
Article in English | MEDLINE | ID: mdl-7712514

ABSTRACT

1. To understand better the mechanisms which govern the sensitivity of secretory vesicles to a calcium stimulus, we compared the abilities of injected chromaffin granule membranes and of endogenous cortical granules to undergo exocytosis in Xenopus laevis oocytes and eggs in response to cytosolic Ca2+. Exocytosis of chromaffin granule membranes was detected by the appearance of dopamine-beta-hydroxylase of the chromaffin granule membrane in the oocyte or egg plasma membrane. Cortical granule exocytosis was detected by release of cortical granule lectin, a soluble constituent of cortical granules, from individual cells. 2. Injected chromaffin granule membranes undergo exocytosis equally well in frog oocytes and eggs in response to a rise in cytosolic Ca2+ induced by incubation with ionomycin. 3. Elevated Ca2+ triggered cortical granule exocytosis in eggs but not in oocytes. 4. Injected chromaffin granule membranes do not contribute factors to the oocyte that allow calcium-dependent exocytosis of the endogenous cortical granules. 5. Protein kinase C activation by phorbol esters stimulates cortical granule exocytosis in both Xenopus laevis oocytes and X. laevis eggs (Bement, W. M., and Capco, D. G., J. Cell Biol. 108, 885-892, 1989). Activation of protein kinase C by phorbol ester also stimulated chromaffin granule membrane exocytosis in oocytes, indicating that although cortical granules and chromaffin granule membranes differ in calcium responsiveness, PKC activation is an effective secretory stimulus for both. 6. These results suggest that structural or biochemical characteristics of the chromaffin granule membrane result in its ability to respond to a Ca2+ stimulus. In the oocytes, cortical granule components necessary for Ca(2+)-dependent exocytosis may be missing, nonfunctional, or unable to couple to the Ca2+ stimulus and downstream events.


Subject(s)
Calcium/pharmacology , Chromaffin Granules/metabolism , Cytoplasmic Granules/metabolism , Exocytosis/drug effects , Animals , Cyclic AMP-Dependent Protein Kinases/metabolism , Dopamine beta-Hydroxylase/metabolism , Egtazic Acid/pharmacology , Exocytosis/physiology , Female , Intracellular Membranes/drug effects , Intracellular Membranes/metabolism , Ionomycin/pharmacology , Lectins/metabolism , Oocytes/cytology , Oocytes/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Xenopus laevis
8.
J Cell Biol ; 116(2): 359-65, 1992 Jan.
Article in English | MEDLINE | ID: mdl-1730760

ABSTRACT

We have devised a new method that permits the investigation of exogenous secretory vesicle function using frog oocytes and bovine chromaffin granules, the secretory vesicles from adrenal chromaffin cells. Highly purified chromaffin granule membranes were injected into Xenopus laevis oocytes. Exocytosis was detected by the appearance of dopamine-beta-hydroxylase of the chromaffin granule membrane in the oocyte plasma membrane. The appearance of dopamine-beta-hydroxylase on the oocyte surface was strongly Ca(2+)-dependent and was stimulated by coinjection of the chromaffin granule membranes with InsP3 or Ca2+/EGTA buffer (18 microM free Ca2+) or by incubation of the injected oocytes in medium containing the Ca2+ ionophore ionomycin. Similar experiments were performed with a subcellular fraction from cultured chromaffin cells enriched with [3H]norepinephrine-containing chromaffin granules. Because the release of [3H]norepinephrine was strongly correlated with the appearance of dopamine-beta-hydroxylase on the oocyte surface, it is likely that intact chromaffin granules and chromaffin granule membranes undergo exocytosis in the oocyte. Thus, the secretory vesicle membrane without normal vesicle contents is competent to undergo the sequence of events leading to exocytosis. Furthermore, the interchangeability of mammalian and amphibian components suggests substantial biochemical conservation of the regulated exocytotic pathway during the evolutionary progression from amphibians to mammals.


Subject(s)
Calcium/physiology , Chromaffin Granules/physiology , Exocytosis , Animals , Cattle , Cytoplasm/physiology , Dopamine beta-Hydroxylase/metabolism , Fluorescent Antibody Technique , Inositol 1,4,5-Trisphosphate/pharmacology , Ionomycin/pharmacology , Microinjections , Norepinephrine/metabolism , Oocytes , Xenopus laevis
SELECTION OF CITATIONS
SEARCH DETAIL
...